Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)

NCT00526552 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2010-03-30

No results posted yet for this study

Summary

To evaluate the efficacy of rosuvastatin in Korean dyslipidemia patients with diabetes

Conditions

Sponsors & Collaborators

Principal Investigators

  • Hyunah Caroline Choi · AstraZeneca Korea

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2007-08-31
Completion
2007-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00526552 on ClinicalTrials.gov